Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220) - Image 1

£76.38

Springer Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Name: Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)
Brand: Springer
Price: 76.38 GBP
Availability: InStock

Medical Technology

This is the most expensive it has ever been. Walk away.

£76 today · previous high £76 · all-time low £75

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 72 days · 72 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 72 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £75 (41 days, 56.9%)

Price range: £75 - £76

Price levels: 2 different prices over 72 days

Description

This book is aimed to summarise the key aspects of the role of circulating tumour cells (CTCs) in breast cancer, with special attention to their contribution to tumour progression and establishment of metastatic disease. We aim to give a clear overview of the knowledge about CTCs, framed in the context of breast cancer, by analysing basic and clinical research carried out so far. In a broader sense, we will address what are the main clinical needs of this disease based on its molecular heterogeneity (subtypes) and lay out the knowledge and understanding that CTCs are giving about it and how they are contributing and can still improve the better monitoring and management of breast cancer patients. We will discuss the evidences of the use of CTCs as a tool to monitor cancer progression and therapy response, based on the prognostic and predictive value they have, as well as a tool to unravel mechanisms of resistance to therapy and to identify new biomarkers allowing to predict therapy success. Moreover, we will analyse the main aspects of ongoing clinical trials and how they can contribute to determine the clinical utility of CTCs as a breast cancer biomarker. We will also touch upon general knowledge or basic notions of the biology of the metastatic process in epithelial cancers, in order to understand the origin and biology of CTCs. In this sense, we will pay special attention to EMT (epithelial to mesenchymal transition), dormancy and minimal residual disease, three key aspects that determine the outcome of the disease. We will also cover general aspects on the isolation and characterization techniques applies to the study of CTCs, and also the possibilities that the study of CTCs, as a biomarker with biological function, is opening in terms of understanding the biology of metastatic cells and the identification of therapeutic targets based on the functional and molecular characterization of CTCs. Lastly, we will try to foresee the future of CTCs in terms of clinical application and implementation in the clinical routine.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3030358070
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Medical Technology
Domain: Amazon UK
Release Date: 18 April 2021
Listed Since: 22 March 2021

Barcode

No barcode data available

Springer Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Cellular Cancer Markers: 12 (Contemporary Biomedicine, 12)

TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease: 64 (Results and Problems in Cell Differentiation)

Metastasis Research Protocols: 58 (Methods in Molecular Medicine)

Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)

Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)

Circulating Tumor Cells (CTCs): Detection Methods, Health Impact & Emerging Clinical Challenges

Intercellular Communication in Cancer

Cancer Biology

Environmental Factors, Genes, and the Development of Human Cancers

Springer - Targeting the Wnt Pathway in Cancer - Oncology Book

Targeted Therapies in Oncology

Springer - Environmental Factors, Genes, and Human Cancers

Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)

Mutant p53 and MDM2 in Cancer: 85 (Subcellular Biochemistry, 85)

Springer Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry 85

New Developments in Metastasis Suppressor Research

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Influence of Tumor Development on the Host: 3 (Cancer Growth and Progression, 3)

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Encyclopedia of Cancer and Society